Zydus Lifesciences appoints Akhil Monappa, Upasana Kamineni Konidela as new Independent Directors

"We hereby inform that the Board of Directors of the Company at their meeting held today i.e. November 29, 2022, based on the recommendation of the Nomination and Remuneration Committee and subject to the approval of shareholders by way of special resolution, approved the appointment of Mr. Akhil Monappa and Ms. Upasana Kamineni Konidela as the Independent Directors of the Company for the first term of 5 (five) consecutive years," the company stated in a BSE filing.

Mr. Akhil Monappa has a background in technology in both investing and operating roles. As an investment professional, he has invested in both early-stage technology companies (while at Atlas Venture, London) and global public market companies (while at Generation Investment Management, London) where he has advised boards and management on strategy and capital allocation decisions. As an operating executive at C-Bridge Internet Solutions in Cambridge, USA, he has developed go-to-market partnerships with some of the leading technology companies as well as held various technical and pre-sales roles.

He holds graduate degrees from Harvard in business and international development and an undergraduate degree in electrical engineering from Georgia Tech, Atlanta.